Life Scientist > Biotechnology

Pancreatic cancer drug targets scar-like tumour tissue

06 October, 2023

The drug known as PXS‐5505 returns the tumour microenvironment to a more 'normal' state by reducing fibrosis and decreasing tumour stiffness.


Breakthrough drug targets life-threatening 'bad cholesterol'

26 September, 2023

The oral drug muvalaplin is claimed to provide world-first treatment for lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke.


Transplanting patients' own lung cells could 'cure' COPD

25 September, 2023

Researchers have shown that it is possible to repair damaged lung tissue in patients with chronic obstructive pulmonary disease (COPD) using the patients' own lung cells.


Australian-developed blood cancer treatment approved by FDA

22 September, 2023

The FDA has approved GSK's cancer drug Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis in adults with anaemia.


DNA-based drug to prevent blood clots

08 September, 2023

Researchers have proposed a side effect-free anticoagulating treatment that has so far proved effective in test mice and could be ready for human trials in just a few years.


Medication for heart conditions improves melanoma treatment

07 September, 2023

Administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma in mouse models of the disease.


Blood cancer drug attacks dormant HIV cells

05 September, 2023

An existing blood cancer drug has shown promise in killing 'silent' HIV cells and delaying reinfection, which could lead to a future cure for the disease.


Eppendorf SciVario twin bioreactor control system

01 September, 2023

The SciVario twin is a next-generation bioreactor control system suitable for microbial and cell culture applications.


Cancer drug prevents EMT, metastasis and more

29 August, 2023

Blocking epithelial–mesenchymal transition (EMT) in tumours reduces their ability to give rise to metastases and sensitises the tumour cells to chemotherapy.


Diabetes drug could promote healthy aging

22 August, 2023

Metformin is a first-line medication for type 2 diabetes, with evidence suggesting the drug may promote healthy aging.


Sartorius Biostat STR bioreactor with Repligen XCell ATF technology

21 August, 2023

Sartorius and Repligen Corporation have launched an integrated bioreactor system that incorporates Repligen XCell ATF upstream intensification technology into Sartorius's Biostat STR bioreactor.


Moderna opens Melbourne research centre, partners with Monash

17 August, 2023

Moderna has opened its Regional Centre for Respiratory Medicines and Tropical Diseases in Melbourne, as well as its new headquarters for Australia, New Zealand, South-East Asia & Oceania.


FDA approves first known pill for postpartum depression

14 August, 2023

Zurzuvae (zuranolone) is understood to be the first and only oral medication indicated to treat adults with postpartum depression (PPD).


Molecular Devices 3D biology portfolio

31 July, 2023

Molecular Devices' robust portfolio of end-to-end high-throughput solutions, user-friendly AI-powered data analysis and committed 3D biotechnology investments should support users in overcoming all their 3D biology challenges.


Pharmacists develop a cheeky solution for drug delivery

20 July, 2023

Researchers have developed a novel oral film that discreetly releases drugs into the bloodstream via the mucosal membrane — the moist, inner lining of the mouth.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd